Showing results (1861-1870 of 1,996) with videos related to
Sort By:
Pageof 200
The Lancet. Neurology|May 15, 2022
Cell-based and stem-cell-based treatments for spinal cord injury: evidence from clinical trialsCarl M Zipser, Jacquelyn J Cragg, James D Guest, et al.The Lancet. Neurology|June 17, 2021
2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosisMike P Wattjes, Olga Ciccarelli, Daniel S Reich, et al.The Lancet. Neurology|March 22, 2020
Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort studyAnna He, Bernd Merkel, James William L Brown, et al.The Lancet. Neurology|September 19, 2020
Neurological disease in adults with Zika and chikungunya virus infection in Northeast Brazil: a prospective observational studyMaria Lúcia Brito Ferreira, Maria de Fatima Pessoa Militão de Albuquerque, Carlos Alexandre Antunes de Brito, et al.The Lancet. Neurology|November 26, 2020
Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trialBardia Nourbakhsh, Nisha Revirajan, Bridget Morris, et al.The Lancet. Neurology|December 19, 2020
APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approachesAlberto Serrano-Pozo, Sudeshna Das, Bradley T HymanThe Lancet. Neurology|December 20, 2020
Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association studyEdwin Jabbari, Shunsuke Koga, Rebecca R Valentino, et al.The Lancet. Neurology|January 28, 2020
Interpretation of risk loci from genome-wide association studies of Alzheimer's diseaseShea J Andrews, Brian Fulton-Howard, Alison GoateThe Lancet. Neurology|November 1, 2020
Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trialJerry S Wolinsky, Douglas L Arnold, Bruno Brochet, et al.The Lancet. Neurology|September 26, 2022
Imaging of the optic nerve: technological advances and future prospectsValérie Biousse, Helen V Danesh-Meyer, Amit M Saindane, et al.Pageof 200